Join our Community
Support ToI and remove all ads
Learn more
×

Kåre Schultz

Teva CEO Kare Schultz at a press conference in Tel Aviv, February 19, 2019 (Shoshanna Solomon/Times of Israel)
May 7, 2020, 4:00 pm
Teva’s shares surge as first quarter results beat expectations
Strong results due to greater demand for generic and OTC products and respiratory products, says pharmaceutical firm president and CEO Kåre Schultz
By Shoshanna Solomon
Kåre Schultz, CEO and president of Teva. (Courtesy)
February 19, 2019, 3:03 pm
Teva sees 25% of US EpiPen auto-injector market by end 2019
In first press conference in Israel, CEO of troubled Israeli drugmaker Kare Schultz says company is still in ‘tough situation’; focus will be on generics and biopharmaceuticals
By Shoshanna Solomon
Kåre Schultz, CEO and president of Teva. (Courtesy)
January 8, 2019, 3:07 pm
Troubled Teva’s CEO sees prices in generic drug market stabilizing
Kare Schultz says at conference he expects sales of flagship Copaxone for multiple sclerosis to ‘continue to decline next year’ as forecast
By Shoshanna Solomon
Teva Pharmaceutical Industries employees protest in front of the Prime Minister's Office in Jerusalem against the company's plan to lay off hundreds of workers, December 17, 2017.(Yonatan Sindel/Flash90)
August 15, 2018, 5:01 am
Warren Buffett boosts bet on ailing drugmaker Teva
Oracle of Omaha buys almost 3 million more shares of generics behemoth after company says restructuring plan on schedule despite protests over layoffs last year
By AP and ToI Staff
The Horsham, Pennsylvania, offices of Teva Pharmaceuticals (AP Photo/George Widman)
July 8, 2018, 3:18 pm
Israel’s Teva to move US HQ from Pennsylvania to New Jersey
Relocation follows 10-year, $40 million tax incentive plan; NJ Governor Phil Murphy announces the news
By Shoshanna Solomon
Teva's facility in Har Hotzvim, Jerusalem (Nati Shohat/Flash90)
May 3, 2018, 8:28 pm
Teva reports jump in first-quarter earnings, raises guidance
After aggressive restructuring, generic drug maker posts net income of $1.06 billion despite 10% drop in sales
By Josef Federman
Kåre Schultz, CEO and president of Teva. (Courtesy)
February 8, 2018, 9:17 pm
Teva chief reports ‘strong progress’ in restructuring plan
CEO Kåre Schultz says company headquarters will remain in Israel despite shake-up that will slash a quarter of local workforce
By Josef Federman
Teva Pharmaceutical Industries employees protest in front of the Prime Minister's Office in Jerusalem against the company's plan to lay off hundreds of workers, December 17, 2017.(Yonatan Sindel/Flash90)
December 31, 2017, 2:13 pm
Teva agrees to delay some layoffs at Jerusalem plant
Pharma firm’s management says facility is to close by 2019 as planned; expects protesting employees to return to work on Monday
By Shoshanna Solomon
Prime Minister Benjamin Netanyahu speaks at a Likud rally marking the Hanukkah holiday in Tel Aviv on December 19, 2017. (Flash90)
December 20, 2017, 5:45 pm
Netanyahu under pressure
Hebrew dailies not impressed by PM’s latest dismissal of allegations against him and takedown of police, accuse him of being ‘petty’ toward rivals
By Adiv Sterman
Teva employees and their families demonstrate outside the Prime Minister's Office in Jerusalem over the company's plan to lay off some 1,700 employees, on December 19, 2017. (Hadas Parush/Flash90)
December 19, 2017, 4:56 pm
Teva rejects Netanyahu’s request to keep Jerusalem plants open
Kare Schultz, CEO of pharma giant, pledges to maintain global HQ in Israel; will retrain laid-off workers, help them find other jobs
By Shoshanna Solomon
Teva employees protest at the entrance to the Ministry of Finance in Jerusalem, December 18, 2017. (Yonatan Sindel/Flash90)
December 19, 2017, 11:44 am
Teva workers blockade Jerusalem industrial park as PM, CEO set to meet
Thousands of employees expected at mass protest outside Netanyahu’s office over planned job cuts amid pharma giant’s restructuring
By ToI Staff
Teva employees protest at the entrance to the Teva Pharmaceutical Industries building in Jerusalem on December 18, 2017. (Yonatan Sindel/Flash90)
December 18, 2017, 5:53 pm
To stay credible as free economy, Israel must swallow Teva’s bitter pill
Amid uproar over layoffs, economists say state should butt out of the pharma company’s decisions, focus instead on finding new jobs for its workers and figuring out what went wrong
By Shoshanna Solomon
Prime Minister Benjamin Netanyahu and Finance Minister Moshe Kahlon attend the weekly cabinet meeting in Jerusalem on August 5, 2015. (Marc Israel Sellem/Flash90/Pool)
December 14, 2017, 11:19 pm
Netanyahu, Kahlon vow to limit Teva layoffs, prevent Jerusalem factory closure
CEO Kare Schultz assures PM he’s committed to keeping Teva’s global HQ in Israel, but says there is no alternative to job cuts to save the company
By Shoshanna Solomon and ToI Staff
Kåre Schultz, CEO and president of Teva. (Courtesy)
December 14, 2017, 6:23 pm
In letter to Israeli PM, Teva CEO apologizes for drug-maker’s sorry state
Kare Schultz assures Netanyahu he is committed to keeping Teva’s global HQ in Israel; says there is no alternative to job cuts to save the company
By Shoshanna Solomon
Employees of Teva Pharmaceutical Industries protest against the company's plan to lay off 1,700 employees, in Kiryat Shmona, December 14, 2017. (Basel Awidat/Flash90)
December 14, 2017, 2:17 pm
Israel’s ailing Teva to cut 25% of global workforce in recovery effort
14,000 workers to be laid off in 2-year restructuring plan, which aims to reduce company’s total cost base by $3 billion by end of 2019
By Shoshanna Solomon
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.